Walter Reed Army Institute of Research begins phase 2 clinical trial of Ebola vaccine

(The U.S. Military HIV Research Program (MHRP)) The Walter Reed Army Institute of Research (WRAIR) today began a Phase 2 clinical trial to evaluate the safety and immunogenicity of a prime-boost Ebola vaccine regimen in both healthy and HIV-infected study volunteers.

http://www.eurekalert.org/pub_releases/2016-01/tumh-wra010616.php

Source: EurekAlert! - Infectious and Emerging Diseases - January 6, 2016 Category: Infectious Diseases Source Type: news